0.228  -0.04 (-14.89%)		11-07 16:00
Open: 0.2599 High: 0.2599 Volume: 971,396		Pre. Close: 0.2679 Low: 0.223 Market Cap: 8(M)

Short term
Mid term
Targets	6-month :	0.38	1-year :	0.46
Resists	First :	0.33	Second :	0.39
Pivot price	0.31
Supports	First :	0.22	Second :	0.18
MAs	MA(5) :	0.27	MA(20) :	0.31
	MA(100) :	0.4	MA(250) :	0.92
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	11	D(3) :	10
RSI	RSI(14): 34.7
52-week	High :	2.01	Low :	0.22

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SRXH ] has closed below the lower bollinger band by 2.9%. Bollinger Bands are 1.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.26 - 0.26	0.26 - 0.26
Low:	0.22 - 0.22	0.22 - 0.22
Close:	0.24 - 0.24	0.24 - 0.24

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.

Thu, 06 Nov 2025
SRX Health Solutions, Inc. Common Stock (NYSE:SRXH) Stock Quote - Markets Financial Content

Thu, 06 Nov 2025
SRx Health Solutions Provides Response Related to Unusual - GlobeNewswire

Thu, 06 Nov 2025
SRx Health Solutions (NYSE American: SRXH) notes unusual trading; no new developments - Stock Titan

Fri, 31 Oct 2025
SRx Health Solutions Completes Private Placement for $15.23M - MSN

Fri, 17 Oct 2025
$4M equity threshold: SRx Health Solutions receives NYSE notice; plan due Nov 13, 2025 - Stock Titan

Fri, 17 Oct 2025
SRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.